Drylab

Filter datasets

Product

Sample

Tags

Collection
219 datasets

Oncology

Tumor and cancer-related samples.

Datasets(Total 219 datasets)
Product
Species
Anatomical entity
Disease state
Software
10k Cells from a MALT Tumor - Gene Expression with a Panel of TotalSeq™-B Antibodies
HumanImmunologyOncology
Universal 3'
Human
Blood
B-Cell Tumor (MALT)
Cell Ranger
10k Human Diseased PBMCs (ALL) Fixed
HumanImmunologyOncology
Universal 5'
Human
Blood
Cancer
Cell Ranger
10k Human Diseased PBMCs (ALL) Fixed and Stored for One Month
HumanImmunologyOncology
Universal 5'
Human
Blood
Cancer
Cell Ranger
10k Human Diseased PBMCs (ALL) Freshly Processed
HumanImmunologyOncology
Universal 5'
Human
Blood
Cancer
Cell Ranger
A CRISPR/Cas9 library screening identified CARM1 as a critical inhibitor for Sorafenib-induced ferroptosis in hepatocellular carcinoma cells
HumanOncologySingle CellMASLD
CRISPR screen; Expression profiling by high throughput sequencing, GPL24676
human
Liver
MASLD/NAFLD/NASH
A CRISPR/Cas9 library screening identified CARM1 as a critical inhibitor for Sorafenib-induced ferroptosis in hepatocellular carcinoma cells [CRISPR screen]
HumanOncologySingle CellMASLD
CRISPR screen; Other, GPL20301
human
Liver
MASLD/NAFLD/NASH
A Metabolic Switch Controlling Liver Cancer Evolution from Senescent NASH Hepatocytes
MouseOncologySingle CellMASLD
Expression profiling by high throughput sequencing, 24247
mouse
Liver
MASLD/NAFLD/NASH
A Metabolic Switch Controlling Liver Cancer Evolution from Senescent NASH Hepatocytes
MouseOncologySingle CellMASLD
Expression profiling by high throughput sequencing, 24247
mouse
Liver
MASLD/NAFLD/NASH
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma
HumanMouseOncologyMASLD
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing, GPL24676;24247;21273
human
Liver
MASLD/NAFLD/NASH
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma [ATAC-seq]
MouseOncologySingle CellMASLD
Genome binding/occupancy profiling by high throughput sequencing, 21273
mouse
Liver
MASLD/NAFLD/NASH
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma [RNA-seq]
HumanMouseOncologyMASLD
Expression profiling by high throughput sequencing, GPL24676;24247
human
Liver
MASLD/NAFLD/NASH
A NEW PRECLINICAL MODEL OF WESTERN DIET-INDUCED PROGRESSION OF NON-ALCOHOLIC STEATOHEPATITIS TO HEPATOCELLULAR CARCINOMA
MouseOncologySingle CellMASLD
Expression profiling by high throughput sequencing, 21626
mouse
Liver
MASLD/NAFLD/NASH
A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
OncologySingle CellMASLD
Q Exactive HF
unspec
Liver
MASLD/NAFLD/NASH
A preclinical mouse model of nonalcoholic steatohepatitis and hepatocellular cancer that mimics human disease
HumanMouseOncologyMASLD
Expression profiling by array, 6887
mouse
Liver
MASLD/NAFLD/NASH
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
HumanImmunologyOncologyMASLD
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing, GPL20301
human
Liver
MASLD/NAFLD/NASH
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma [ChIP-seq]
HumanImmunologyOncologyMASLD
Genome binding/occupancy profiling by high throughput sequencing, GPL20301
human
Liver
MASLD/NAFLD/NASH
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma [RNA-seq]
HumanImmunologyOncologyMASLD
Expression profiling by high throughput sequencing, GPL20301
human
Liver
MASLD/NAFLD/NASH
ATG9A-PLA2G6 axis reprograms phospholipid metabolism to drive metabolic liver disease and hepatocellular carcinoma
OncologySingle CellMASLD
metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - hilic; Liquid Chromatography MS - negative - hilic
unspec
Liver
MASLD/NAFLD/NASH
Activated Interferon Signaling Suppresses Age-Dependent Liver Cancer
OncologySingle CellMASLD
—
Liver
MASLD/NAFLD/NASH
Activated Interferon Signaling Suppresses Age-Dependent Liver Cancer [CosMx_Stat1KO]
MouseOncologySingle CellMASLD
CosMx SMI; Other, GPL36279
Mus musculus
Liver
MASLD/NAFLD/NASH

Showing 1–20 of 219